Remifentanil-sevoflurane anaesthesia for laparoscopic cholecystectomy: Comparison of three dose regimens

Anaesthesia

Volumn 57, Issue 3, 2002, Pages 212-217

  Van Delden, P G ^a   Houweling, P L ^b   Bencini, A F ^c   Ephraim, E P ^d   Frietman, R C ^a   Van Niekerk, J ^a   Van Stolk, M A ^e   Verheijen, R ^f   Wajer, O J M ^g   Mulder, P G H ^h  

^a Gelre Ziekenhuisen Apeldoorn ^*  (Netherlands)

^b DEPARTMENT OF SURGERY   (Netherlands)

^c MARTINI HOSPITAL   (Netherlands)

^d ZAANS MEDICAL CENTER   (Netherlands)

^e SINT FRANCISCUS GASTHUIS   (Netherlands)

^f MEDISCH SPECTRUM TWENTE   (Netherlands)

^g Ziekenhuis Rivierenland   (Netherlands)

^h ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

Anaesthetics: volatile; sevoflurane; Analgesics: remifentanil; Recovery

Indexed keywords

PROPOFOL; REMIFENTANIL; SEVOFLURANE;

ADULT; AGED; ANESTHESIA; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ARTICLE; CHOLECYSTECTOMY; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG POTENTIATION; ELECTIVE SURGERY; FEMALE; HEALTH CARE QUALITY; HUMAN; INCIDENCE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NAUSEA; PAIN; RANDOMIZED CONTROLLED TRIAL; UNCONSCIOUSNESS;

ADULT; ANESTHESIA RECOVERY PERIOD; ANESTHETICS, COMBINED; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; CHOLECYSTECTOMY, LAPAROSCOPIC; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; METHYL ETHERS; MIDDLE AGED; PIPERIDINES; POSTOPERATIVE COMPLICATIONS;

EID: 0036186740     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0003-2409.2001.02465.x     Document Type: Article

References (12)

1. Clinical uses of fentanyl, sufentanil, and alfentanil
2. Design, synthesis, and pharmacological evaluation of ultrashort- to long-acting opioid analgetics
3. Remifentanil: A truly-short-acting opioid
4. Remifentanil: A novel, short-acting, mu-opioid
5. Remifentanil pharmacokinetics and pharmacodynamics: A preliminary appraisal
6. A review of the pharmacokinetics and pharmacodynamics of remifentanil
7. Pharmacokinetic / pharmacodynamic evaluation of remifentanil, GR90291, and alfentanil
8. Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia
9. Remifentanil, an esterase-metabolised opioid. What advantages does it offer in analgesia and anaesthesia?
10. Reduction of isoflurane minimal alveolar concentration by remifentanil
11. Awareness in anaesthesia. Incidence, consequences and prevention
12. 2O anesthesia